Search results for "Median survival"

showing 9 items of 9 documents

Strategie des chirurgischen Vorgehens beim hilären Cholangiokarzinom

2006

Surgery is the decisive life-prolonging treatment in patients with hilar cholangiocarcinoma. Surgery is mainly based on empiric data. Since patients without surgery have only about 6 months to survive, to achieve a high resection rate is crucial for these patients. During diagnostic workup, percutaneous transhepatic cholangiography results in the most reliable assessment of longitudinal tumor growth. The extent of the tumor is frequently overestimated leading to the consequence of excluding the patients from surgery. En-bloc resection of the tumor and the adjacent liver should be the preferred surgical approach. So far, surgical radicality (right trisegmentectomy, extended lymphadenectomy a…

medicine.medical_specialtySurgical approachbusiness.industrymedicine.medical_treatmentOperative mortalityPercutaneous transhepatic cholangiographySurgerymedicine.anatomical_structuremedicineSurgeryTumor growthIn patientVascular resectionbusinessLymph nodeMedian survivalZentralblatt für Chirurgie
researchProduct

Outcomes of Donor-Recipient Gender Mismatched Lung Transplantation in the Eurotransplant Area

2019

Purpose An effect of donor-recipient gender mismatching on long-term survival outcomes following organ transplantation has been postulated but remains controversial. We aimed to investigate the influence of gender mismatches on long-term survival after lung transplantation in the Eurotransplant area. Methods In this retrospective, multicentre study in the Eurotransplant area, all lung transplants performed from DBD lungs in the period from 01.01.2000 until 31.12.2015 were included. A total of 7688 lung transplant recipients (≥ 14 years old) for long-term survival and the effect of gender mismatches (Kaplan-Meier, multivariate regression). Results More men (4079; 52 %) were transplanted comp…

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtyLung transplantsLungbusiness.industrymedicine.medical_treatmentOrgan transplantationmedicine.anatomical_structureInternal medicineMedicineLung transplantationSurgeryCardiology and Cardiovascular MedicinebusinessMedian survival
researchProduct

Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study

1989

The incidence, prevalence and natural course of ALS were determined in the population of the province of Palermo, Italy. The average annual incidence calculated for the years 1973 through 1984, was 044./100.000 inhabitants. The prevalence rate on prevalence day December 31, 1984, was 1.67/100.000 population. The male/female ratio was 1.38. The mean age at onset was 54.3±11.02. The most common clinical form was the conventional one (61.4%); the bulbar form was more frequent among females than males. The mean duration of the disease was 33.7±35.8 months. The longest duration belongs to the pseudopolyneuritic form. The median survival was 36 months: 16 months for the bulbar, 36 months for the …

AdultPediatricsmedicine.medical_specialtyAdolescentprevalencePopulationPrevalenceDermatologyAnnual incidenceEpidemiologyHumansMedicineAmyotrophic lateral sclerosisChildeducationAgedAged 80 and overNatural courseeducation.field_of_studyNeuroscience (all)business.industryGeneral NeuroscienceIncidence (epidemiology)Amyotrophic Lateral SclerosisInfant NewbornInfantGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthItalyChild PreschoolincidenceSettore MED/26 - NeurologiaNeurology (clinical)businessMedian survivalAmyotrophic Lateral SclerosiThe Italian Journal of Neurological Sciences
researchProduct

Prognostic Implications of the Standardized Study of Resection Margins in Pancreatic Cancers

2013

Abstract Introduction Involvement of surgical resection margins is a fundamental prognostic factor in pancreatic oncological surgery. However, there is a lack of standardized histopathology definition. The aims of this study are to investigate the real rate of R1 resections when surgical specimens are evaluated according to a standardized protocol and to study its survival implications. Patients and methods One hundred consecutive surgically resected patients with pancreatic ductal adenocarcinoma were included in the study. They were further divided into 2 groups: pre-protocol, evaluated before the introduction of the standardized protocol and post-protocol, analyzed with the standardized p…

AdultAged 80 and overMalePrognostic factormedicine.medical_specialtyPancreatic ductal adenocarcinomabusiness.industryGeneral EngineeringOncological surgeryMiddle AgedPrognosismedicine.diseaseSurgeryResectionPancreatic NeoplasmsPancreatic cancermedicineHumansFemaleHistopathologybusinessMedian survivalAgedRetrospective StudiesR0 resectionCirugía Española (English Edition)
researchProduct

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

2020

[Abstract] Introduction and objectives. The age of heart transplant recipients and donors is progressively increasing. It is likely that not all donor-recipient age combinations have the same impact on mortality. The objective of this work was to compare survival in transplant recipients according to donor-recipient age combinations. Methods. We performed a retrospective analysis of transplants performed between 1 January 1993 and 31 December 2017 in the Spanish Heart Transplant Registry. Pediatric transplants, retransplants and combined transplants were excluded (6505 transplants included). Four groups were considered: a) donor < 50 years for recipient < 65 years; b) donor < 50 years for r…

medicine.medical_specialtyPrognostic factorTrasplante cardiacoMultivariate analysisSurvivalCombinaciones de edad de donante y receptor Donor age Donor/recipient age combinations Edad del donante Edad del receptor Heart transplant Recipient age Supervivencia Survival Trasplante cardiacoEnfermedad cardiovascularDonor/recipient age combinationsRecipient age030204 cardiovascular system & hematologyDonor age03 medical and health sciences0302 clinical medicineInternal medicineRetrospective analysisEdad del receptorMedicineHumansTrasplante de corazónRegistriesChildRetrospective StudiesSupervivenciabusiness.industryEdad del donanteGraft SurvivalAge FactorsCombinaciones de edad de donante y receptorGeneral MedicineTissue DonorsTransplant RecipientsTrasplante de órganosDatos estadísticosHeart TransplantationHeart transplantSupervivencia tisularbusinessMedian survival
researchProduct

Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature.

2004

Cryotherapy has gained importance as a locally ablative treatment option for patients with non-resectable liver tumors, especially metastases from colorectal cancer. We have used this technique since 1996 for the treatment of 77 patients with malignant liver tumors. Patient data was prospectively recorded and follow-up was until September 2002 or death. Fifty-five patients had colorectal cancer liver metastases, 16 metastases from other primaries and 6 had hepatoma. Forty patients had cryotherapy only and 37 had an additional liver resection. Morbidity and mortality were 22% and 1.3%, respectively. In 68% of patients with colorectal liver metastases and an elevated serum carcinoembryonic a…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCryotherapyBreast NeoplasmsGastroenterologyCryosurgeryCryosurgeryResectionElevated serum03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansProspective StudiesNormal rangeAgedbusiness.industryLiver NeoplasmsPatient dataMiddle Agedmedicine.diseaseTreatment OutcomeOncology030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleNeoplasm Recurrence LocalbusinessColorectal NeoplasmsMedian survivalFollow-Up StudiesTechnology in cancer researchtreatment
researchProduct

Association between the multidimensional prognostic index and mortality during 15 Years of Follow-up in the InCHIANTI Study

2020

Abstract Background Multidimensional Prognostic Index (MPI) is recognized as a prognostic tool in hospitalized patients, but data on the value of MPI in community-dwelling older persons are limited. Using data from a representative cohort of community-dwelling persons, we tested the hypothesis that MPI explains mortality during 15 years of follow-up. Methods A standardized comprehensive geriatric assessment was used to calculate the MPI and to categorize participants in low-, moderate-, and high-risk classes. The results were reported as hazard ratios (HRs) and the accuracy was evaluated with the area under the curve (AUC), with 95% confidence intervals (CIs) and the C-index. We also report…

Agingmedicine.medical_specialtyIndex (economics)THE JOURNAL OF GERONTOLOGY: Medical SciencesInCHIANTI Mortality Multidimensional prognostic index Prognosis030204 cardiovascular system & hematologyAge and sex03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineMedicineHumans030212 general & internal medicineGeriatric AssessmentAgedAged 80 and overbusiness.industryHazard ratioArea under the curveGeriatric assessmentPrognosisConfidence intervalCohortFemaleIndependent LivingGeriatrics and GerontologybusinessMedian survivalFollow-Up Studies
researchProduct

DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus?

1991

In 45 patients who underwent an esophagus resection due to a squamous cell carcinoma, in addition to the TNM classification and usual morphologic criteria, the paraffin-embedded material underwent deparaffinization, was rehydrated, and was mechanically and enzymatically processed into a single-cell solution. For evaluating the DNA histogram this was analyzed with the help of automatic single-cell cytophotometric study. The method, contrary to that of flow cytometric study, allows for the selective analysis of tumor cells due to the electronically, previously given selection criteria, whereas artifacts, stroma, and infection cells remain excluded from analysis. The multivariate analysis show…

MaleCancer ResearchPathologymedicine.medical_specialtyEsophageal NeoplasmsTumor cellsResectionStromaEsophagus CarcinomamedicineHumansBasal cellEsophagusDNA Image CytometryNeoplasm StagingPloidiesbusiness.industryDNA NeoplasmPrognosisSurvival Analysismedicine.anatomical_structureOncologyLymphatic MetastasisCarcinoma Squamous CellFemaleCytophotometrybusinessMedian survivalCancer
researchProduct

Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

2022

Abstract Background An enhanced surveillance schedule has been proposed for cirrhotics with viral etiology, who are considered at extremely high-risk of hepatocellular carcinoma (HCC). Aims We compared the 3- and 6-months surveillance interval, evaluating cancer stage at diagnosis and patient survival. Methods Data of 777 HBV and HCV cirrhotic patients with HCC diagnosed under a 3-months (n = 109, 3MS group) or a 6-months (n = 668, 6MS group) surveillance were retrieved from the Italian Liver Cancer database. Survival in the 3MS group was considered as observed and adjusted for lead-time bias, and survival analysis was repeated after a propensity score matching. Results The 3-months surveil…

medicine.medical_specialtyCarcinoma HepatocellularSurvivalHepatocellular carcinomaCancer stageCancer stage; Hepatocellular carcinoma; Surveillance interval; SurvivalInternal medicinemedicineHumansPropensity ScoreSurveillance intervalSurvival analysisHigh risk patientsHepatologybusiness.industryCancer stageLiver NeoplasmsSettore MED/09 - MEDICINA INTERNAGastroenterologyPatient survivalmedicine.diseaseSurvival AnalysisHepatocellular carcinomaPropensity score matchingSurvival AnalysiLiver cancerbusinessMedian survivalHuman
researchProduct